HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Marra Selected Research

DNA (Deoxyribonucleic Acid)

12/2019Therapeutic Implication of Genomic Landscape of Adult Metastatic Sarcoma.
1/2019Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer.
6/2012DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma.
6/2009Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Marra Research Topics

Disease

18Neoplasms (Cancer)
10/2020 - 01/2007
3Breast Neoplasms (Breast Cancer)
09/2021 - 01/2007
2Neoplasm Metastasis (Metastasis)
01/2022 - 04/2013
2Carcinogenesis
09/2021 - 01/2015
2Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 01/2018
2Brain Neoplasms (Brain Tumor)
01/2018 - 01/2014
2Glioma (Gliomas)
01/2018 - 01/2014
2Intellectual Disability (Idiocy)
06/2014 - 10/2010
2Leukemia
03/2013 - 01/2011
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2024
1Uveal melanoma
01/2022
1Vitiligo
01/2022
1Tuberous Sclerosis (Bourneville's Disease)
12/2019
1Sarcoma (Soft Tissue Sarcoma)
12/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2018
1Desmosterolosis
06/2014
1Lymphoma (Lymphomas)
12/2013
1Blast Crisis (Blast Phase)
03/2013
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2013
1Oligodendroglioma
06/2012
1Medulloblastoma
04/2012
1Prostatic Neoplasms (Prostate Cancer)
03/2012
1Neuroendocrine Carcinoma
03/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2011
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2010
1ATR-X syndrome
10/2010
1Thrombocytosis (Thrombocythemia)
01/2010
1Neutropenia
01/2010
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2007
1Uterine Cervical Dysplasia
12/2007
1Iron Overload
08/2002

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
09/2021 - 12/2007
4DNA (Deoxyribonucleic Acid)IBA
12/2019 - 06/2009
4RNA (Ribonucleic Acid)IBA
01/2019 - 01/2011
2EverolimusFDA Link
09/2021 - 12/2019
2Tyrosine (L-Tyrosine)FDA Link
01/2016 - 12/2013
2Phosphotransferases (Kinase)IBA
01/2016 - 12/2013
2Proteins (Proteins, Gene)FDA Link
04/2014 - 10/2010
2Tyrosine Kinase InhibitorsIBA
12/2013 - 03/2013
1Immunoglobulins (Immunoglobulin)IBA
01/2024
1NivolumabIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1IpilimumabIBA
01/2022
1Irinotecan (Camptosar)FDA LinkGeneric
09/2021
1Capecitabine (Xeloda)FDA Link
09/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2021
1Bevacizumab (Avastin)FDA Link
09/2021
1Paclitaxel (Taxol)FDA LinkGeneric
09/2021
1TOR Serine-Threonine KinasesIBA
12/2019
1Proto-Oncogene Proteins c-etsIBA
01/2019
1veliparibIBA
01/2018
1MethyltransferasesIBA
01/2018
1Temozolomide (Temodar)FDA LinkGeneric
01/2018
1Calcibiotic Root Canal SealerIBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2015
1Histones (Histone)IBA
01/2015
1CholesterolIBA
06/2014
1Glutamate Receptors (Glutamate Receptor)IBA
06/2014
1N,N'-bis(4-azidobenzoyl)cystineIBA
01/2014
1PhosphotyrosineIBA
12/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2013
1AcidsIBA
06/2012
1Formaldehyde (Formol)FDA Link
04/2012
1ParaffinIBA
04/2012
15'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
03/2012
1Capsules (Microcapsules)IBA
03/2012
1Messenger RNA (mRNA)IBA
03/2012
1MicroRNAs (MicroRNA)IBA
01/2011
1GlobinsIBA
10/2010
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2010
1Contrast MediaIBA
12/2007
1Gefitinib (Iressa)FDA Link
01/2007
1ErbB Receptors (EGF Receptor)IBA
01/2007
1Transferrin Receptors (Transferrin Receptor)IBA
08/2002

Therapy/Procedure

9Therapeutics
01/2022 - 01/2007
2Drug Therapy (Chemotherapy)
09/2021 - 11/2017
1Immunotherapy
01/2022
1Precision Medicine
10/2020
1Heterologous Transplantation (Xenotransplantation)
04/2013